Literature DB >> 29177671

Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy.

Chunqing Guo1,2,3, John R Subjeck4, Xiang-Yang Wang5,6,7.   

Abstract

Large heat shock proteins (HSPs) or stress proteins, including Hsp110 and Grp170, are unique molecular chaperones with superior capability of shuttling tumor protein antigens into professional antigen-presenting cells, such as dendritic cells, for highly efficient cross-presentation and T cell priming. Reconstituted chaperone complexes of large HSP and tumor protein antigen have been demonstrated to generate a robust antigen-specific T lymphocyte response with therapeutic potency against multiple cancer types in preclinical models. Here, we describe the methods for preparing this recombinant chaperone complex vaccine and analyzing the vaccine-induced activation of antigen-specific T cells using in vitro and in vivo systems.

Entities:  

Keywords:  Antigen cross-presentation; Chaperone vaccine; Grp170; Hsp110; Large heat shock protein; T cell activation

Mesh:

Substances:

Year:  2018        PMID: 29177671      PMCID: PMC5812279          DOI: 10.1007/978-1-4939-7477-1_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

1.  The chaperoning activity of hsp110. Identification of functional domains by use of targeted deletions.

Authors:  H J Oh; D Easton; M Murawski; Y Kaneko; J R Subjeck
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

2.  HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway.

Authors:  Ramunas M Vabulas; Parviz Ahmad-Nejad; Sanghamitra Ghose; Carsten J Kirschning; Rolf D Issels; Hermann Wagner
Journal:  J Biol Chem       Date:  2002-02-12       Impact factor: 5.157

3.  CD91: a receptor for heat shock protein gp96.

Authors:  R J Binder; D K Han; P K Srivastava
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

4.  Evaluation of renal cell carcinoma vaccines targeting carbonic anhydrase IX using heat shock protein 110.

Authors:  Hyung L Kim; Xiaolei Sun; John R Subjeck; Xiang-Yang Wang
Journal:  Cancer Immunol Immunother       Date:  2006-12-05       Impact factor: 6.968

Review 5.  The hsp110 and Grp1 70 stress proteins: newly recognized relatives of the Hsp70s.

Authors:  D P Easton; Y Kaneko; J R Subjeck
Journal:  Cell Stress Chaperones       Date:  2000-10       Impact factor: 3.667

6.  Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity.

Authors:  X Y Wang; L Kazim; E A Repasky; J R Subjeck
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

7.  Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma.

Authors:  Xiang-Yang Wang; Hilal Arnouk; Xing Chen; Latif Kazim; Elizabeth A Repasky; John R Subjeck
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

8.  Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation.

Authors:  Yves Delneste; Giovanni Magistrelli; Jean Gauchat; Jean Haeuw; Jean Aubry; Kayo Nakamura; Naoko Kawakami-Honda; Liliane Goetsch; Tatsuya Sawamura; Jean Bonnefoy; Pascale Jeannin
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

9.  Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells.

Authors:  Brent Berwin; Justin P Hart; Stuart Rice; Cecilia Gass; Salvatore V Pizzo; Steven R Post; Christopher V Nicchitta
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

10.  Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.

Authors:  Xiang-Yang Wang; Xiaolei Sun; Xing Chen; John Facciponte; Elizabeth A Repasky; John Kane; John R Subjeck
Journal:  J Immunol       Date:  2010-05-03       Impact factor: 5.422

View more
  4 in total

1.  Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patients.

Authors:  Michael M Wach; John R Subjeck; Xiang-Yang Wang; Elizabeth Repasky; Junko Matsuzaki; Han Yu; Chong Wang; Daniel Fisher; Joseph J Skitzki; John M Kane
Journal:  Melanoma Res       Date:  2022-04-01       Impact factor: 3.199

Review 2.  Nanomaterials for Protein Delivery in Anticancer Applications.

Authors:  Anne Yau; Jinhyung Lee; Yupeng Chen
Journal:  Pharmaceutics       Date:  2021-01-25       Impact factor: 6.321

3.  Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy.

Authors:  Masoud Delfi; Rossella Sartorius; Milad Ashrafizadeh; Esmaeel Sharifi; Yapei Zhang; Piergiuseppe De Berardinis; Ali Zarrabi; Rajender S Varma; Franklin R Tay; Bryan Ronain Smith; Pooyan Makvandi
Journal:  Nano Today       Date:  2021-03-11       Impact factor: 18.962

Review 4.  Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy.

Authors:  Gaëtan Jego; François Hermetet; François Girodon; Carmen Garrido
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.